chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Blood clots, one on the lung; Gonna pass out; Extremely dizzy; Lightheaded; Little bit of soreness after injection; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PULMONARY EMBOLISM (Blood clots, one on the lung) and LOSS OF CONSCIOUSNESS (Gonna pass out) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included COPD and Diabetes. Concomitant products included INSULIN and OMEPRAZOLE for an unknown indication.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced VACCINATION SITE PAIN (Little bit of soreness after injection). On 04-Apr-2021, the patient experienced LOSS OF CONSCIOUSNESS (Gonna pass out) (seriousness criterion medically significant), DIZZINESS (Extremely dizzy) and DIZZINESS (Lightheaded). On 06-Apr-2021, the patient experienced PULMONARY EMBOLISM (Blood clots, one on the lung) (seriousness criteria hospitalization and medically significant). On 03-Apr-2021, VACCINATION SITE PAIN (Little bit of soreness after injection) had resolved. On 04-Apr-2021, LOSS OF CONSCIOUSNESS (Gonna pass out) and DIZZINESS (Extremely dizzy) had resolved. At the time of the report, PULMONARY EMBOLISM (Blood clots, one on the lung) outcome was unknown and DIZZINESS (Lightheaded) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Products known to have been used by the patient, within two weeks prior to the event, included medications for (diabetic) nerve pain and inhalers used for chronic obstructive pulmonary disease.  Treatment for the event included blood thinners.  Based on the current available information and temporal association between the use of the product and the start date of the event vaccination site pain, a causal relationship cannot be excluded. Very limited information regarding the events loss of consciousness, dizziness, and pulmonary embolism has been provided at this time. However, the patient's underlying medical conditions remains as confounders. Further information is not expected.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event vaccination site pain, a causal relationship cannot be excluded. Very limited information regarding the events loss of consciousness, dizziness, and pulmonary embolism has been provided at this time. However, the patient's underlying medical conditions remains as confounders. Further information is not expected.
30 days after receiving last dosage, I received pneumonia vaccine and felt like swelling right side of brain and stiffness left side of neck. Lasted for about 24 to 36 hours.  Reporting make public aware of the receipt of pneumonia vaccine after COVID vaccine
Patient received incorrect dose of Pfizer vaccine for age.  Dr, Pediatrician contacted parents, explained the situation and answered all questions. Dr. made a plan for a second dose.
Pt had just received vaccine and stated he "wasnt feeling well", and laid down on the floor.  Pt assisted from floor to wheel chair and vitals obtained : BP 150/80, HR 118, RR 20, SpO2 97% RA.  PT complained of headache, nausea, and not being able to walk.  Pt father advised EMS that pt "often get's emotional and works himself up like this" and did not show concern to Pt state.  Pt stated he wanted to go to the hospital, Pt father insisted that he take Pt to hospital via POV.  Pt father signed refusal of TP form, and PT care TF to Pt father.
Erythema, edema, warmth, tenderness on (R) thigh-began evening of appt increased size and discomfort over 24 hours. TX: symptomatic care -> BENADRYL/warm/cool compress.
armpit swelled on his left arm and it is ongoing; fever; Body ache; This spontaneous case was reported by a patient and describes the occurrence of AXILLARY MASS (armpit swelled on his left arm and it is ongoing), PYREXIA (fever) and MYALGIA (Body ache) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 04B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, the patient experienced AXILLARY MASS (armpit swelled on his left arm and it is ongoing), PYREXIA (fever) and MYALGIA (Body ache). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. On 26-Apr-2021, PYREXIA (fever) and MYALGIA (Body ache) had resolved. At the time of the report, AXILLARY MASS (armpit swelled on his left arm and it is ongoing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.
Extreme body aches, nausea, head ache, etc. Extreme flu like symptoms that is worsening instead improving.
Fever, chills and headache during the night (3AM) Fever (up to 102.2F) lasted 24 hours.
Viral syndrome. Treated for otitis media finished Augmenton 2/21. Fever 105+, fussy, mom states seizure at home. Admitted for observation , IV fluids, tylenol , has URI. Dx = viral syndrome, febrile seizure.
body aches, chills, mild congestion, cough, some headache, fever (100), sore throat. starting 12/19/21
feeling of throat closing/HTN/drop in O2 sat, itchy throat dizziness
FELT LIKE SOMETHING HAD HAPPENED; HIT A WALL OF TIREDNESS; FEVER; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced felt like something had happened, hit a wall of tiredness, and fever. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) Bit of temperature. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from felt like something had happened, hit a wall of tiredness, and fever. This report was non-serious.
I had a cold before discovering that I had Sinusitis on 04/27/2023 this happen few months after receiving my 4th vaccine. I had a cold above the neck. I had facial tenderness and runny nose. I went to my doctor's office on 04/27/2023 after explaining my symptoms to my doctor she prescribed me with Antibiotics.
On 1/23/13, patient reported muscle pain from the arm where shot was administered. Patient described it as "ache that comes and goes". On a scale of 1-10, patient stated pain is 5. Patient denied any induration, inflammation / swelling on the arm. Patient denied having pain in other body parts. Patient did warm compress and took Ibuprofen on 1/24/13.
Pain in shoulder. Limited range of movement in shoulder.  X-rays negative.  Currently in week 4 of physical therapy.
22 hours after the second Pfizer vaccine dose patient developed a fever and malaise. Next day she was so stiff and sore she could not raise herself on the couch to take the Tylenol and Ibubrofen. I had to put the meds in her mouth while she was lying down and give her sips of water with a straw. She had chills, fever and stiffness for two weeks and we were snowed in. Finally got her to her medical doctor.
This spontaneous report as received from a pharmacist refers to a 81 years old female patient with cholesterol and hypertension and no known drug reaction allergies. The patient was vaccinated in left arm with a dose of ZOSTAVAX (dose, route and lot # not reported) on 30-JUL-2012. No other co-suspects were reported. There were unspecified concomitant medications. The pharmacist stated that the patient was vaccinated with ZOSTAVAX and on approximately August 2012 unspecified date she developed a red, itchy rash below the injection site of the the arm. The patient would follow-up with her health care provider. The patient had sought medical attention called pharmacist. No specify treatment information was reported. No other information was provided. At the time of the report, the patient had not recovered from red, itchy rash below the injection site of the left arm. The relatedness for red itchy rash below the injection site of the left arm was unknown for ZOSTAVAX. Additional information is not expected.
Red raised papules, rashes on trunk (front-back) few on face, neck, thighs & arms.
The Department came to the work place to give COVID19 vaccines. Approximately 4 hours after receiving the 1st dose of the COVID vaccine, the patient/staff c/o feeling dizzy / double vision/ headache .  her Blood pressure was high / blood sugar wnl she was becoming sluggish lungs were clear she was sent out to ED via EMS . She reported to this RN after the event that she was kept in the hospital until just before 2:00 am where they had her on IV fluids to bring her BP down.
fatigue; Three patients have been seen in follow-up visits and have reported mild injection site pain; This is a spontaneous report received from contactable reporter(s) (Physician) from a sales representative.  An elderly patient received rsv vaccine prot.subunit pref 2v (RSV VACCINE PROT.SUBUNIT PREF 2V), in Oct2023 as dose number unknown, single (Batch/Lot number: unknown) for immunisation; for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset Oct2023, outcome "unknown", described as "Three patients have been seen in follow-up visits and have reported mild injection site pain"; FATIGUE (non-serious), outcome "unknown". Therapeutic measures were not taken as a result of vaccination site pain, fatigue.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300362807 Same product and event, different patient;US-PFIZER INC-202300362808 Same product and event, different patient;
Experienced momentary loss of hearing (seconds duration) in each ear, which seemed to resolve; have persistent tinnitus in both ears; This is a spontaneous report from a contactable consumer (patient himself).  A 47-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, lot number: EP7533) via an unspecified route of administration on 05Apr2021 at 11:45 am as a single dose for COVID-19 immunisation. The patient's medical history included Allergy and GERD. The patient's concomitant medications were not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient's 2 weeks prior vaccines included omeprazole, daily vitamin B-12, D3. Prior to vaccination, patient was not diagnosed with COVID-19. COVID vaccination was none. Since the vaccination, patient had not been tested for COVID-19. COVID tested post vaccination was none. On 08Apr2021 at 11pm, the patient reported that she experienced momentary loss of hearing (seconds duration) in each ear, which seemed to resolve, but currently she has persistent tinnitus in both ears. The patient reported that she did not take any treatment for the events and the events led to physician visit. Outcome of events was not resolved.
Got vaccine and 2 years later got shingles; I only got one shot; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, 2 years after receiving Shingles vaccine and not applicable after receiving Shingles vaccine, the patient experienced shingles and incomplete course of vaccination. On an unknown date, the outcome of the shingles and incomplete course of vaccination were unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient received dose of Shingles vaccine and 2 years later experienced shingles. The patient stated that no one told him/her that he/she could still get it. The patient later heard that it was a 2-step vaccine and the patient only got one shot. Till the time of reporting, the patient did not receive the 2nd dose, which led to incomplete course of vaccination. The follow-up would not possible as no contact details were available.
Ever since I got the tetnus shot in my right arm. I have had very bad pain every morning I wake up it just hurts so bad. I have to have to have help changing  my shirt because it hurts to lift my arm or bend it in certain ways. I even have issues lifting things at work with that arm or reaching for things up high. I just took a shower and pulled my scrunchie off the wall that was suctioned cupped to the wall with my right arm and it just hurt so bad. This is keeping me from doing things in my everyday life.
pt devel fever 103 ax & hives on face & ears;eyes were swollen;MOC gave APAP & motrin alternately & gave DPH;
Vaccine was administrated beyond use date after the thaw process; This spontaneous case was reported by a paramedic and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine was administrated beyond use date after the thaw process) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030h21b) for COVID-19 prophylaxis.     It was unknown if the patient had ever been diagnosed with or tested positive for COVID-19. It was unknown if the patient had any acute illness at the time of vaccination and up to one month before. It was also unknown if the patient had any chronic or long-standing health conditions.     On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was administrated beyond use date after the thaw process). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine was administrated beyond use date after the thaw process) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Age of the patient was reported as 21 years and 9 months.  Concomitant medication of the patient was not reported.  The patient did not experience any adverse reactions after the administration of vaccine.  No treatment information was provided by the reporter.
Moderate swelling of entire left shoulder deltoid muscle, red stripe leading from shot site toward lymph node, pain in armpit. Pain and swelling lasted four days in total.
Rash and small hives appeared on upper chest, groin and both forearms on October 20,  In next few days rash expanded to 50% of body including hands, arms, legs and back with intense itch in the extremities (hands and feet)  Treatment with Prednisone and Benadryl over the next four days successfully treated most symptoms.
Slight discomfort at site of vaccination during arm movement from 6pm on day of vaccination until 10pm next day.   No other sign or symptom as of 1/21/2021 11:03AM
15OCT numbness & pain lt arm & numbness of index, middle & third fingers;dx radiculitis;
burning sensation down arm beginning p/inj; pain & tingling @ site & unable to bend @ elbow; 1 1/2hr p/shot c/o inflammation & swelling traveling down arm lt chest & around back; also feels weak;
AFib; This is a spontaneous report from a contactable physician via Pfizer Sales Representative. A 68-year-old male patient received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13) intramuscular in the left deltoid muscle on his left arm on 07Oct2019 at 0.5 mg single dose for pneumonia and invasive pneumococcal disease. Medical history included chronic coronary artery disease, Gastrooesophageal reflux disease (GERD), anxiety, and bleeding hemorrhoids.  Concomitant drugs when the patient was on at the time he received the pneumococcal 13-val conj vac (dipht crm197 protein) included amlodipine 5 mg once daily orally, acetylsalicylic acid (ASPIRIN 81) at 81 mg once daily orally, atenolol 55mg once a day by mouth, atorvastatin 40mg once a day by mouth, apixaban (ELIQUIS) 5mg twice a day by mouth, losartan 50mg once a day by mouth, sildenafil citrate (VIAGRA) 100 mg, sertraline hydrochloride (ZOLOFT) 150mg once a day by mouth.  Serious adverse event was reported as A-fib with onset date of 07Oct2019and seriousness criterion of hospitalization. The event clinical course was as follows: The patient went into A-fib on 07Oct2019. It was unknown exactly when A-fib began, but the patient went right to the hospital when it did begin. Patient was not in the provider's office when it began, it was sometime later that day, and the patient never told the provider until recent visit this year in Sep. It was unknown if the patient was admitted when he went to the hospital that day.  Outcome of the event was resolved.    Information on the lot/batch number has been requested.; Sender's Comments: Based on the information currently provided, A-fib occurrence most likely is associated with the patient underlying cardiovascular condition unlikely related to PREVNAR 13 use.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Case number PHEH2014US024083, is an initial spontaneous report received from a medical assistant on 01 Dec 2014. This report refers to a 25 year old female patient. Her medical history and concomitant medication were not reported. She was vaccinated with FLUVIRIN (batch number: 1412801) intramuscularly on 22 Oct 2014. After vaccination she experienced redness and heat at injection site. The patient fully recovered from the events on 29 Oct 2014. Seriousness and causality were not reported.
A cluster of 2 adult patients who received TUBERSOL, lot number C2910AA, and developed injection site redness and induration four days after the test had been read as negative. Initial report received on 26 September 2008 from a healthcare professional. A 41 year old female patient, with no medical history and no known allergies, received on 16 September 2008 a first left foramen intradermal injection of TUBERSOL (lot number C2910AA) and a first right deltoid intramuscular injection of ADACEL (lot number C2995BA). The tuberculin test was read as "0/0 negative" (0 redness and 0 induration) on 18 September 2008. On 22 September 2008, four days after the negative test result, the patient had redness and induration of unknown size at the TUBERSOL injection site on the left forearm. Corrective treatment was not reported. The patient had no illness at the time of testing, was taking no concomitant medications and had no other vaccines given in the previous four weeks. At the time of the report, 26 September 2008, the patient had recovered. Case 2008-02998 with the same reporter and same TUBERSOL lot number was created for the other patient.
Rash 2-4 weeks after vaccine. Rash papular on trunk and extremities.
Patient presented to the ED several times within 6 weeks of receiving COVID vaccination. ED visits on 3/12/21, 3/16/21, 3/7/21, 3/20/21, 3/28/21, and 3/30/21. He also presented to the ED on 3/30/21 and was hospitalized at that time. These visits were within 6 weeks of receiving COVID vaccination.
dry mouth; swelling redness at injection site; swelling redness at injection site; tired; chills; wasn't feeling herself; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE,Lot Number: EN5318; Expiry date: Unknown), dose 2 via an unspecified route of administration, administered in Arm Left on 10Feb2021 at SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On 11Feb2021, the patient experienced tired and chills, after 3 days on 13Feb2021, dry mouth, swelling redness at injection site and swelling redness at injection site and wasn't feeling herself. The patient stated that after receiving the vaccine she was fine and went to sleep that day, it was the next day on 11Feb2021 is when she experienced the chills and being tired. She didn't go out, she wasn't feeling herself. The injection site was noticed around the 3rd day, she had a band aid on it, she was instructed to keep the band aid on for a couple days, she noticed the injection site symptoms around the 13Feb2021. She is calling because she wants to know if she can take any kind of medicine like aspirin. She hasn't gotten out of bed, she is tired. She is still experiencing all the symptoms reported. The outcome of the event was not recovered.
PERSON ADMITTED TO HOSPITAL ON 1/15/22 AFTER BECOMING LETHARGIC, TACHYPNEIC. PERSON REQUIRED BILEVEL POSITIVE PRESSURE VENTILATION AND APPEARED SEPTIC.  PREVIOUSLY POSITIVE FOR COVID-19 AND HOSPITALIZED IN OCTOBER 2020. SENT TO ICU AND IMMEDIATELY INTUBATED.  PERSON'S CONDITION REMAINED CRITICAL AND WENT INTO CARDIAC ARREST; FAMILY CHANGED CODE STATUS TO DNR AND PERSON DIED UPON RECURRENT CARDIAC ARREST.
Since the second injection I've lost the ability to speak. Along with quite a lot of pain in my throat. As I'm not a doctor I couldn't say if it is vaccine related, but one thing followed the other.
Redness and swelling noted to RUE. Patient complained of pain. Encouraged patient to take ibuprofen at home as needed and apply ice pack as needed. Informed to see doctor if symptoms persist.
Post menopausal bleeding began two weeks after first shot in March, bleeding has been persistent for six months.
Patient stated that his right knee hurt within 1 hour of vaccination. The pain was severe enough that he had to use a cane. The pain had subsided by 6am the following day. He has had knee replacement done but this was not the knee that surgery was done on. He is sure this was related to vaccine.
Felt cruddy; Body aches; Chills; Tiredness; Arm  tenderness; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Felt cruddy), PAIN (Body aches), CHILLS (Chills), FATIGUE (Tiredness) and TENDERNESS (Arm  tenderness) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in November 2020.    On 17-Mar-2021 at 3:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced ILLNESS (Felt cruddy), PAIN (Body aches), CHILLS (Chills), FATIGUE (Tiredness) and TENDERNESS (Arm  tenderness). On 21-Mar-2021, ILLNESS (Felt cruddy), PAIN (Body aches), CHILLS (Chills), FATIGUE (Tiredness) and TENDERNESS (Arm  tenderness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient was taking allergy shots. Patient wanted to know if she could take Ibuprofen or Tylenol.